Media & Resources

IAVI welcomes news that the Government of Japan has awarded the 2013 Hideyo Noguchi Africa Prize to two leaders of the global campaign to address the suffering caused by AIDS and end the HIV pandemic: Dr. Alex Coutinho, Executive Director of the Infectious Diseases Institute in Kampala, Uganda, and Dr. Peter Piot, Director of the…

Women the world over have made enormous progress in obtaining the right to lead their lives as they choose. IAVI applauds that progress and lends its unequivocal support to the continuing struggle to ensure equal rights and protections for all women, everywhere. Addressing the HIV epidemic among women is a big part of that struggle.…

IAVI is very pleased to share some important news regarding the new appointments of two highly-valued, integral senior staff in our Medical Affairs Department. Pat Fast, most recently Chief Medical Officer at IAVI, has transitioned into the role ofSenior Technical Advisor in Research and Development, effective February 1, 2013.  Pat will have specific responsibilities in IAVI’s…

Prototype candidate and potential new method to help prevent infection via broadly neutralizing antibodies will be assessed for safety, tolerability, durability NEW YORK – IAVI, the International AIDS Vaccine Initiative, today announced the start of a Phase I clinical trial in the U.K. examining a prototype candidate and a potential new method to prevent HIV infection.…

Although antiretroviral treatment and current prevention options have considerably reduced HIV infections and AIDS-related deaths, a safe and effective vaccine is needed to end the global AIDS pandemic expeditiously and sustainably, according to a new commentary from Anthony S. Fauci, M.D., Director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the…

Proof-of-concept for vaccine candidate that can elicit broadly neutralizing antibodies could be applied to HIV, other challenging viruses NEW YORK – IAVI, the International AIDS Vaccine Initiative, congratulates researchers at The Scripps Research Institute (TSRI) for successfully employing new “designer proteins” to create a vaccine that, in preclinical studies, was shown to  elicit broadly neutralizing…

Dr. Reinhard Kurth, a leading biomedical scientist who served as Chair of the IAVI Scientific Advisory Committee from June 2010 to June 2013 and a member of the IAVI Board of Directors, passed away on February 2, 2014.  Dr. Kurth leaves a strong legacy of public service and commitment to public health in Germany and…

The International AIDS Vaccine Initiative (IAVI) congratulates Deborah Birx, MD, on her nomination as the next U.S. Global AIDS Coordinator.  “Dr. Birx is a longtime advocate for a robust and comprehensive global response to HIV and AIDS that includes a vaccine,” said IAVI CEO Margie McGlynn. “She is a strong champion of innovative approaches and tools…